Merck (MRK) Current Assets (2009 - 2026)

Merck (MRK) has reported Current Assets for 18 consecutive years, with $36.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 1.04% year-over-year to $36.7 billion in Q2 2026; TTM through Jun 2026 was $36.7 billion, a 1.04% decrease from a year earlier, with the FY2025 full-year figure at $43.5 billion, up 12.21% from the prior year.
• Current Assets was $36.7 billion for Q2 2026 at Merck, up from $35.0 billion in the prior quarter.
• Over five years, Current Assets peaked at $47.6 billion in Q3 2025 and troughed at $30.0 billion in Q2 2023.
• A 5-year average of $35.8 billion and a median of $35.3 billion in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets decreased 9.95% in 2023 and climbed 27.45% in 2024, its largest moves.
• Over 5 years, Current Assets stood at $35.7 billion in 2022, then decreased by 9.95% to $32.2 billion in 2023, then grew by 20.56% to $38.8 billion in 2024, then advanced by 12.21% to $43.5 billion in 2025, then declined by 15.71% to $36.7 billion in 2026.
• The last three Current Assets figures came in at $36.7 billion (Q2 2026), $35.0 billion (Q1 2026), and $43.5 billion (Q4 2025), per Business Quant data.